Skip to content
  • Home
  • Journalists
    • Headlines
  • Community
    • Businesses
    • Jobs
    • Learning
    • Marketplace
  • Store
(@)

How Private Equity Oversees the Ethics of Drug Research

Many drug trials are vetted by companies with ties to the drugmakers, raising concerns about conflicts of interest and patient safety.

Walt Bogdanich
Author: Walt Bogdanich

Written by

Walt Bogdanich Carson Kessler and Jeremy Singer-Vine

in

Clinical Trials, Conflicts of Interest, Drugs (Pharmaceuticals), Ethics and Official Misconduct, GLP-1 RAs (Drug), Mergers, Acquisitions and Divestitures, Novo Nordisk A/S, Ozempic (Drug), Private Equity, Regulation and Deregulation of Industry, Research
←An American Way of Dress
More Retirees Are Living on Less, and Losing a Means of Help to Pay for Medicare→

More posts

  • Fiona Cauley & Inevitable Foundation Are Making The Disabled Community “The Main Character” In New Digital Series ‘Talking Sh*t’

  • Lexington Film Office Launches Workforce Development Initiative With Location Managers Guild

  • European grocery chains’ freezers, refrigerators targeted in apparent cyberattacks

  • Newsom proposes $1 billion cap for film and TV tax incentive

About Us


Support Us

Trademark & Copyright 1998 – 2025 · MOSAEC

  • Facebook
  • Instagram
  • LinkedIn
  • YouTube